Showing results (281-290 of 322) with videos related to

Sort By:
Pageof 33
BMC Cancer|July 30, 2011
Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)Seok Jin Kim, Chul Won Choi, Yeung-Chul Mun, et al.
Blood Research|October 19, 2017
Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trialJeongkuk Seo, Won Seog Kim, Jin Seok Kim, et al.
Blood Advances|April 26, 2022
Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2Kerry J Savage, Steven M Horwitz, Ranjana Advani, et al.
Annals of Hematology|March 30, 2010
Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safetySung Sook Lee, Cheolwon Suh, Bong-Seog Kim, et al.
Leukemia & Lymphoma|September 29, 2015
A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trialSung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
Scientific Reports|August 10, 2020
Genetic heterogeneity and prognostic impact of recurrent ANK2 and TP53 mutations in mantle cell lymphoma: a multi-centre cohort studySeri Jeong, Yu Jin Park, Woobin Yun, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2013
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study GroupSeok Jin Kim, Chiun Hsu, Yu-Qin Song, et al.
Oncotarget|November 8, 2017
The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160)Sung-Hoon Jung, Je-Jung Lee, Kihyun Kim, et al.
Leukemia & Lymphoma|April 25, 2007
Clinical features and treatment outcomes of angioimmunoblastic T-cell lymphomaByeong-Bae Park, Baek-Yeol Ryoo, Jae H Lee, et al.
Annals of Hematology|January 4, 2020
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphomaYoung-Woong Won, Hyewon Lee, Hyeon-Seok Eom, et al.
Pageof 33